iShares U.S. Pharmaceuticals ETF Rating → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free IHE Stock Alerts $63.31 +0.58 (+0.92%) (As of 04/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy2.59Holdings in IHE have an aggregate rating of Moderate Buy based on 257 analyst ratings issued in the past year covering 33 companies (99.5% of the portfolio).IHE Aggregate Price Target$79.5825.69% UpsideHigh Prediction$100.07Average Prediction$79.58Low Prediction$62.28Holdings in IHE have an aggregate price target of $79.58 and a range of $62.28 to $100.07 covering 33 companies (99.5% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 33 IHE Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings22.75%LLYEli Lilly and Company$733.51+1.2%5 of 5 stars2.84$728.05 -0.7%19Upcoming Earnings22.67%JNJJohnson & Johnson$146.14-0.5%5 of 5 stars2.46$175.86 20.3%134.97%MRKMerck & Co., Inc.$131.20+0.4%5 of 5 stars2.58$131.33 0.1%12Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage4.67%PFEPfizer$25.40+0.6%5 of 5 stars2.38$36.33 43.0%16Upcoming EarningsDividend AnnouncementNews Coverage4.63%RPRXRoyalty Pharma$28.00-0.4%5 of 5 stars3.00$46.75 67.0%4Positive News4.50%VTRSViatris$11.57+0.9%0 of 5 stars1.33$11.00 -4.9%34.48%BMYBristol-Myers Squibb$44.85+0.3%5 of 5 stars2.11$60.00 33.8%19Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage4.30%CTLTCatalent$55.92+0.2%3 of 5 stars2.15$52.46 -6.2%13Analyst ReportNews CoveragePositive News3.90%ZTSZoetis$158.42+3.3%5 of 5 stars3.00$218.00 37.6%7Upcoming EarningsAnalyst Report2.98%ITCIIntra-Cellular Therapies$73.26+1.6%4 of 5 stars2.90$90.17 23.1%10Upcoming EarningsAnalyst ReportAnalyst Revision2.97%JAZZJazz Pharmaceuticals$109.46+1.9%5 of 5 stars2.85$195.08 78.2%13Upcoming EarningsNews Coverage2.74%ELANElanco Animal Health$13.26+1.7%4 of 5 stars2.57$16.71 26.1%7Short Interest ↑1.95%OGNOrganon & Co.$18.55+0.7%5 of 5 stars2.50$21.80 17.5%4Upcoming EarningsNews Coverage1.79%PRGOPerrigo$31.94+2.1%5 of 5 stars3.00$40.67 27.3%3News Coverage1.48%PBHPrestige Consumer Healthcare$70.47+0.5%4 of 5 stars2.50$110.00 56.1%2Analyst RevisionNews Coverage1.13%AXSMAxsome Therapeutics$71.71+0.3%4 of 5 stars2.92$119.67 66.9%121.01%ARVNArvinas$32.37+2.4%3 of 5 stars2.88$59.73 84.5%16Upcoming EarningsNews Coverage0.89%CORTCorcept Therapeutics$22.80+2.7%5 of 5 stars3.00$39.30 72.4%4Upcoming EarningsAnalyst Report0.69%SUPNSupernus Pharmaceuticals$30.07+2.6%4 of 5 stars3.00$41.00 36.3%10.64%AMPHAmphastar Pharmaceuticals$41.11+0.7%5 of 5 stars2.50$66.00 60.5%4Short Interest ↑Positive News0.52%PCRXPacira BioSciences$26.33+3.3%5 of 5 stars3.00$49.50 88.0%10Upcoming EarningsAnalyst RevisionNews Coverage0.51%LGNDLigand Pharmaceuticals$70.57+0.3%5 of 5 stars3.00$116.33 64.8%3Upcoming EarningsShort Interest ↑0.49%COLLCollegium Pharmaceutical$36.42+1.6%2 of 5 stars2.60$39.00 7.1%5Upcoming EarningsAnalyst UpgradeNews Coverage0.42%ANIPANI Pharmaceuticals$65.36+0.6%4 of 5 stars3.00$80.00 22.4%4Analyst ReportShort Interest ↑0.42%EWTXEdgewise Therapeutics$16.17+1.4%2 of 5 stars3.00$31.20 92.9%50.41%HRMYHarmony Biosciences$29.32+1.3%4 of 5 stars2.50$40.63 38.6%8Upcoming EarningsPositive News0.37%TARSTarsus Pharmaceuticals$32.04-0.5%3 of 5 stars2.88$48.38 51.0%8Positive News0.33%SAVACassava Sciences$22.34+2.8%3 of 5 stars3.00$124.00 455.1%1News Coverage0.28%PLRXPliant Therapeutics$11.81-0.6%3 of 5 stars3.00$49.00 314.9%90.26%AMRXAmneal Pharmaceuticals$5.87-0.5%2 of 5 stars3.00$7.31 24.6%4Upcoming EarningsShort Interest ↑News Coverage0.14%TBPHTheravance Biopharma$9.12-0.2%1 of 5 stars3.00$20.50 124.8%2Short Interest ↓0.14%RVNCRevance Therapeutics$3.40+3.3%5 of 5 stars2.50$13.75 304.4%8Short Interest ↓Gap Up0.03%AMLXAmylyx Pharmaceuticals$1.76-1.1%3 of 5 stars2.25$32.67 1,756.1%8Short Interest ↑Negative NewsHigh Trading Volume This page (NYSEARCA:IHE) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
